Quarterly report pursuant to Section 13 or 15(d)

Equity (Details 3)

v3.20.2
Equity (Details 3) - $ / shares
 9 Months Ended 12 Months Ended
May 31, 2020
Aug. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of options outstanding 281,834 234,000
Weighted Average Remaining Contractual life, Outstanding (in years) 9 years 1 month 24 days 9 years 9 months 10 days
Weighted Average Exercise Price $ 3.57  
Options Exercisable Number of shares 139,811  
Options Exercisable Weighted Average Exercise Price $ 3.95  
46,084    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of options outstanding 46,084  
Weighted Average Remaining Contractual life, Outstanding (in years) 8 years 2 months 19 days  
Weighted Average Exercise Price $ 10.80  
Options Exercisable Number of shares 30,244  
Options Exercisable Weighted Average Exercise Price $ 10.80  
2,500    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of options outstanding 2,500  
Weighted Average Remaining Contractual life, Outstanding (in years) 9 years 1 month 20 days  
Weighted Average Exercise Price $ 3.12  
Options Exercisable Number of shares 2,500  
Options Exercisable Weighted Average Exercise Price $ 3.12  
159,250    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of options outstanding 159,250  
Weighted Average Remaining Contractual life, Outstanding (in years) 9 years 3 months  
Weighted Average Exercise Price $ 1.99  
Options Exercisable Number of shares 98,317  
Options Exercisable Weighted Average Exercise Price $ 1.99  
50,000    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of options outstanding 50,000  
Weighted Average Remaining Contractual life, Outstanding (in years) 9 years 6 months 7 days  
Weighted Average Exercise Price $ 2.65  
Options Exercisable Number of shares 6,250  
Options Exercisable Weighted Average Exercise Price $ 2.65  
24,000    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of options outstanding 24,000  
Weighted Average Remaining Contractual life, Outstanding (in years) 9 years 6 months 14 days  
Weighted Average Exercise Price $ 2.12  
Options Exercisable Number of shares 2,500  
Options Exercisable Weighted Average Exercise Price $ 2.12